Clinical approach to penicillin-allergic patients: A survey

Roland Solensky, Harry S. Earl, Rebecca S. Gruchalla

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Background: Approximately 10% of individuals report a history of penicillin allergy. Objective: We chose to survey various physician groups to determine how they would manage penicillin-allergic patients who present with an infectious process for which penicillin is the drug of choice. Methods: In situations where penicillin was the drug of choice, physicians were asked to choose the type of antibiotic treatment for patients who presented with diseases of varying severity and who had either vague or convincing penicillin-allergic histories. Results: A total of 601 surveys were mailed and 93 (16%) were returned. For those patients who present with a vague history of penicillin allergy, 58% and 59% of the physicians surveyed stated that they would choose cephalosporins for individuals with mild and moderate diseases, respectively. In contrast, in the vague penicillin history/severe disease scenario, physicians were split between choosing cephalosporins (42% of responders) and vancomycin (40% of responders). For those patients who present with a convincing history of penicillin allergy, 55% of the physicians chose erythromycin for individuals with mild disease; 44% chose quinolones for individuals with moderate disease, and 63% chose vancomycin for individuals with severe disease. In each of the three disease severities, physicians were significantly more likely to choose cephalosporins for patients with a vague history of penicillin allergy than for patients with a convincing history (each P<10-5). Conclusion: The choice of antibiotics is influenced both by the type of penicillin allergic history and by the severity of the disease process to be treated. To decrease the use of broad- spectrum antibiotics in patients labeled 'penicillin-allergic', an effort should be made to identify, by skin testing, those patients who lack penicillin-specific IgE antibodies.

Original languageEnglish (US)
Pages (from-to)329-333
Number of pages5
JournalAnnals of Allergy, Asthma and Immunology
Volume84
Issue number3
StatePublished - Mar 2000

Fingerprint

Penicillins
Physicians
Hypersensitivity
Cephalosporins
History
Vancomycin
Anti-Bacterial Agents
Surveys and Questionnaires
Quinolones
Erythromycin
Pharmaceutical Preparations
Immunoglobulin E
Skin
Antibodies

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Clinical approach to penicillin-allergic patients : A survey. / Solensky, Roland; Earl, Harry S.; Gruchalla, Rebecca S.

In: Annals of Allergy, Asthma and Immunology, Vol. 84, No. 3, 03.2000, p. 329-333.

Research output: Contribution to journalArticle

@article{dc7701716f844fcdaa4482b875494041,
title = "Clinical approach to penicillin-allergic patients: A survey",
abstract = "Background: Approximately 10{\%} of individuals report a history of penicillin allergy. Objective: We chose to survey various physician groups to determine how they would manage penicillin-allergic patients who present with an infectious process for which penicillin is the drug of choice. Methods: In situations where penicillin was the drug of choice, physicians were asked to choose the type of antibiotic treatment for patients who presented with diseases of varying severity and who had either vague or convincing penicillin-allergic histories. Results: A total of 601 surveys were mailed and 93 (16{\%}) were returned. For those patients who present with a vague history of penicillin allergy, 58{\%} and 59{\%} of the physicians surveyed stated that they would choose cephalosporins for individuals with mild and moderate diseases, respectively. In contrast, in the vague penicillin history/severe disease scenario, physicians were split between choosing cephalosporins (42{\%} of responders) and vancomycin (40{\%} of responders). For those patients who present with a convincing history of penicillin allergy, 55{\%} of the physicians chose erythromycin for individuals with mild disease; 44{\%} chose quinolones for individuals with moderate disease, and 63{\%} chose vancomycin for individuals with severe disease. In each of the three disease severities, physicians were significantly more likely to choose cephalosporins for patients with a vague history of penicillin allergy than for patients with a convincing history (each P<10-5). Conclusion: The choice of antibiotics is influenced both by the type of penicillin allergic history and by the severity of the disease process to be treated. To decrease the use of broad- spectrum antibiotics in patients labeled 'penicillin-allergic', an effort should be made to identify, by skin testing, those patients who lack penicillin-specific IgE antibodies.",
author = "Roland Solensky and Earl, {Harry S.} and Gruchalla, {Rebecca S.}",
year = "2000",
month = "3",
language = "English (US)",
volume = "84",
pages = "329--333",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "3",

}

TY - JOUR

T1 - Clinical approach to penicillin-allergic patients

T2 - A survey

AU - Solensky, Roland

AU - Earl, Harry S.

AU - Gruchalla, Rebecca S.

PY - 2000/3

Y1 - 2000/3

N2 - Background: Approximately 10% of individuals report a history of penicillin allergy. Objective: We chose to survey various physician groups to determine how they would manage penicillin-allergic patients who present with an infectious process for which penicillin is the drug of choice. Methods: In situations where penicillin was the drug of choice, physicians were asked to choose the type of antibiotic treatment for patients who presented with diseases of varying severity and who had either vague or convincing penicillin-allergic histories. Results: A total of 601 surveys were mailed and 93 (16%) were returned. For those patients who present with a vague history of penicillin allergy, 58% and 59% of the physicians surveyed stated that they would choose cephalosporins for individuals with mild and moderate diseases, respectively. In contrast, in the vague penicillin history/severe disease scenario, physicians were split between choosing cephalosporins (42% of responders) and vancomycin (40% of responders). For those patients who present with a convincing history of penicillin allergy, 55% of the physicians chose erythromycin for individuals with mild disease; 44% chose quinolones for individuals with moderate disease, and 63% chose vancomycin for individuals with severe disease. In each of the three disease severities, physicians were significantly more likely to choose cephalosporins for patients with a vague history of penicillin allergy than for patients with a convincing history (each P<10-5). Conclusion: The choice of antibiotics is influenced both by the type of penicillin allergic history and by the severity of the disease process to be treated. To decrease the use of broad- spectrum antibiotics in patients labeled 'penicillin-allergic', an effort should be made to identify, by skin testing, those patients who lack penicillin-specific IgE antibodies.

AB - Background: Approximately 10% of individuals report a history of penicillin allergy. Objective: We chose to survey various physician groups to determine how they would manage penicillin-allergic patients who present with an infectious process for which penicillin is the drug of choice. Methods: In situations where penicillin was the drug of choice, physicians were asked to choose the type of antibiotic treatment for patients who presented with diseases of varying severity and who had either vague or convincing penicillin-allergic histories. Results: A total of 601 surveys were mailed and 93 (16%) were returned. For those patients who present with a vague history of penicillin allergy, 58% and 59% of the physicians surveyed stated that they would choose cephalosporins for individuals with mild and moderate diseases, respectively. In contrast, in the vague penicillin history/severe disease scenario, physicians were split between choosing cephalosporins (42% of responders) and vancomycin (40% of responders). For those patients who present with a convincing history of penicillin allergy, 55% of the physicians chose erythromycin for individuals with mild disease; 44% chose quinolones for individuals with moderate disease, and 63% chose vancomycin for individuals with severe disease. In each of the three disease severities, physicians were significantly more likely to choose cephalosporins for patients with a vague history of penicillin allergy than for patients with a convincing history (each P<10-5). Conclusion: The choice of antibiotics is influenced both by the type of penicillin allergic history and by the severity of the disease process to be treated. To decrease the use of broad- spectrum antibiotics in patients labeled 'penicillin-allergic', an effort should be made to identify, by skin testing, those patients who lack penicillin-specific IgE antibodies.

UR - http://www.scopus.com/inward/record.url?scp=0034071856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034071856&partnerID=8YFLogxK

M3 - Article

C2 - 10752918

AN - SCOPUS:0034071856

VL - 84

SP - 329

EP - 333

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 3

ER -